ROZIBAFUSP ALFA
UNII O9YF5SN7KL

Substance Identification & Data

This profile provides standardized clinical and technical data for Rozibafusp Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) O9YF5SN7KL.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2143449-47-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

O9YF5SN7KL

CAS Registry Number

2143449-47-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ROZIBAFUSP ALFA

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C174794

National Cancer Institute reference terminology for clinical and research data.

INN ID

10975

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-163

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rozibafusp Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ROZIBAFUSP ALFA

Common Names & Synonyms

ANTI-B7RP-1MAB/BAFF

IMMUNOGLOBULIN G2-KAPPA, ANTI-(HUMAN INDUCIBLE COSTIMULATOR (ICOS) LIGAND PROTEIN) HUMAN MONOCLONAL ANTIBODY, FUSED WITH TWO COPIES OF A TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B (TNFSF13B, B-CELL ACTIVATING FACTOR, BAFF)-BINDING PEPTIDE, GLYCOFORM ALFA

ROZIBAFUSP ALFA [INN]

ROZIBAFUSP ALFA [USAN]

ROZIBAFUSP ALFA [WHO-DD]